A

Apogee Therapeutics
D

APGE

134.080
USD
-0.11
(-0.08%)
مغلق
حجم التداول
47,544
الربح لكل سهم
-5
العائد الربحي
-
P/E
-31
حجم السوق
10,140,044,696
المقالات
المزيد

العنوان: Apogee Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for thetreatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies bytargeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.